Search Within

Monica Morrow

  1. "Principal Biostatisticians "
Formats
  1. Journal Article (50)
  2. Meeting Abstract (48)
  3. Miscellaneous (25)
  4. Review (2)
Groups
  1. Epidemiology and Biostatistics (125)
  2. Principal Biostatisticians (125)
  3. Surgery (125)
  4. Survivorship Research (67)
  5. Josie Robertson Surgery Center (60)
  6. Graduate Medical Education (53)

More Groups

People
  1. Srinivasa Sevilimedu Veeravalli (124)
  2. Audree Tadros (53)
  3. Andrea Barrio (48)
  4. Tiana Le (36)
  5. Tracy-Ann Moo (30)
  6. Kate Pawloski (27)

More People

Years
  1. 2025 (5)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (34)
  5. 2021 (29)
  6. 2020 (5)

More Years

Publications
  1. Annals of Surgical Oncology (99)
  2. Journal of Clinical Oncology (7)
  3. Breast Cancer Research and Treatment (5)
  4. JAMA Oncology (3)
  5. Cancer (2)
  6. Cancer Research (2)

More Publications

Publishers
  1. Springer (104)
  2. American Society of Clinical Oncology (7)
  3. American Medical Association (5)
  4. American Association for Cancer Research (2)
  5. Elsevier Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (125)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Omission of routine frozen section among clinically node-negative patients having upfront mastectomy avoids unnecessary axillary treatment
    Meeting Abstract

    Sargent, R.; Sevilimedu, V.; Barrio, A. V.; Morrow, M.; Mamtani, A.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Trends in patient-reported outcomes after breast-conserving surgery and partial breast vs whole breast irradiation
    Meeting Abstract

    Chandler, J. M.; Kim, M.; Sevilimedu, V.; Le, T. V.; Nelson, J. A.; Branunstein, L. Z.; Morrow, M.; Lee, M. K.; Tadros, A. B.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Do HER2-low tumors have a distinct clinicopathologic phenotype?
    Journal Article

    Polidorio, N.; Montagna, G.; Sevilimedu, V.; Le, T.; Morrow, M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Do HER2-low tumors have a distinct clinicopathologic phenotype?
    Miscellaneous

    Polidorio, N.; Montagna, G.; Sevilimedu, V.; Le, T.; Morrow, M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Patient-reported outcomes in patients undergoing lumpectomy with and without defect closure
    Journal Article

    Palmquist, E.; Sevilimedu, V.; Garcia, P.; Le, T.; Zhang, X.; Pinker-Domenig, K.; Hanna, M. G.; Nelson, J. A.; Morrow, M.; El-Tamer, M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Patient-reported outcomes in patients undergoing lumpectomy with and without defect closure
    Miscellaneous

    Palmquist, E.; Sevilimedu, V.; Garcia, P.; Le, T.; Zhang, X.; Pinker-Domenig, K.; Hanna, M. G.; Nelson, J. A.; Morrow, M.; El-Tamer, M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Examining race and patient-reported outcomes after contralateral prophylactic mastectomy with reconstruction
    Journal Article

    Myers, S. P.; Bayard, S.; Tadros, A. B.; Sevilimedu, V.; Matros, E.; Nelson, J. A.; Le, T.; Garcia, P.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Examining race and patient-reported outcomes after contralateral prophylactic mastectomy with reconstruction
    Miscellaneous

    Myers, S. P.; Bayard, S.; Tadros, A. B.; Sevilimedu, V.; Matros, E.; Nelson, J. A.; Le, T.; Garcia, P.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Satisfaction and well being after contralateral prophylactic mastectomy among BRCA mutation carriers and noncarriers—A longitudinal analysis of BREAST Q domains
    Miscellaneous

    Myers, S. P.; Tadros, A. B.; Sevilimedu, V.; Nelson, J. A.; Le, T.; Garcia, P.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Mutational status is associated with a higher rate of pathologic complete response after neoadjuvant chemotherapy in hormone receptor-positive breast cancer
    Journal Article

    Myers, S. P.; Sevilimedu, V.; Barrio, A. V.; Tadros, A. B.; Mamtani, A.; Robson, M. E.; Morrow, M.; Lee, M. K.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save